Predictive model of prostate cancer risk

	Tweet

Combining PSA with other risk factors for prostate cancer (CaP) may result in individualized risk prediction.

In the April 19, 2006 issue of the Journal of the National Cancer Institute, Dr. Ian Thompson and colleagues report a predictive model for CaP based upon the Prostate Cancer Prevention Trial (PCPT) database.

PCPT included 18,882 men with a normal rectal exam and PSA level in a study of chemoprevention using finasteride or placebo over a 7-year period. At the end of the 7-year study period, participants in the placebo group who underwent prostate biopsy were included in this report.  CaP risk modeling was performed using risk variables such as family history of CaP, race, PSA, DRE, previous biopsy history, age, and PSA velocity. Multivariable logistic regression model analyzed the data.

The study cohort consisted of 5,519 men.  Most were Caucasian, and did not have a previous biopsy. Variables statistically associated with an increased risk of CaP included increasing PSA, positive family history, and abnormal DRE. Having a previously negative prostate biopsy was linked to a statistically decreased risk of CaP.

Interestingly, PSA velocity was associated with a 6-fold increase in CaP risk by itself, but in combination with the above significant variables neither PSA velocity nor patient age added independent prognostic information. African Americans had a 40% increased risk of CaP, which was just statistically significant.

The authors point out that the report is limited by patient characteristics not reflecting those of the general population. 

http://www.ncbi.nlm.nih.gov/entrez/

RELATED STORIES:
Prostate cancer vaccines more effective with hormone therapy   Selenium-Protein Deficiency Raises Prostate Cancer Risk   Drug Shows Activity in Men with Advanced Prostate Cancer   Folic Acid Supplements Linked To Higher Risk Of Prostate Cancer   Researchers find new biomarker for fatal prostate cancer   Stem Cells Found in Prostate May Be Involved in Cancer   Prostate cancer clinical stage does not predict recurrence   Prostate Cancer Grading & Staging   Genetic map of prostate cancer cracked   Obesity linked to higher risk of prostate cancer progression   Men often not told of prostate cancer risks: study   New diagnostic tool for prostate cancer   Study backs prostate screening for high risk men   Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy   A Better Blood Test for Prostate Cancer   Chlordecone exposure and risk of prostate cancer   Androgen deprivation therapy does not prevent prostate cancer from spreading   How Advanced Prostate Cancer Becomes Resistant to Androgen-deprivation Therapy   Possible link found between x-rays and prostate cancer   Screening for Prostate Cancer May Not Reduce Men’s Risk of Death   Turmeric holds real potential for the treatment and prevention of prostate cancer   Combination therapy improves survival for certain prostate cancer patients

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]